# ARDX — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-08-10. Informational only, not financial advice.

**Recommendation:** HOLD

**Scores (0–100):** Overall 3.5 · Fundamentals 3.5 · Technicals 4 · Growth 2.5 · Risk 6.5

## Summary

ARDX faces structural headwinds from payer friction on IBSRELA and unresolved XPHOZAH reimbursement, yet shows strong revenue growth (Q2 $120.9M) and gross margins (~95%). The stock is trading near 52-week lows ($4.00) with high short interest (11.07%) and negative operating margins (-8.75%), but technicals suggest a potential rebound toward the forecast band's lower end.

## Price targets (12-month horizon)

- Bear: $3.50
- Base: $4.75
- Bull: $5.34

## News context

Recent news highlights record Q2 revenue ($118M) driven by IBSRELA but missing earnings estimates and trimming guidance due to payer hurdles. Analysts have lowered price targets from $16 to $13, with Zacks adding ARDX to Strong Sell. The stock plunged 22% after the miss, reflecting negative sentiment despite strong revenue growth. However, insider selling (CEO Raab sold $211k) and high short interest (11.07%) indicate bearish positioning.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/ardx-ai-stock-forecast-5f69ebee11a25d0e4eddf62bdf5aa31f
- AI-generated; model outputs can be wrong. Not financial advice.